Conexeu Sciences Inc. (NASDAQ:CNXU) Short Interest Update

Conexeu Sciences Inc. (NASDAQ:CNXU) was the target of a large growth in short interest in May. As of May 29th, there was short interest totaling 21,639 shares, a growth of ∞ from the May 14th total of 0 shares. Based on an average daily trading volume, of 31,620 shares, the short-interest ratio is presently 0.7 days. Currently, 0.1% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded shares of Conexeu Sciences to a “hold” rating in a research note on Saturday, May 30th.

Conexeu Sciences Trading Down 6.9%

Conexeu Sciences stock traded down $0.84 during mid-day trading on Friday, reaching $11.29. The company’s stock had a trading volume of 58,391 shares, compared to its average volume of 93,790. Conexeu Sciences has a 12-month low of $10.87 and a 12-month high of $18.79.

Conexeu Sciences Company Profile

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. — Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property (“IP”) developed over more than a decade at the University of British Columbia (the “University”) and the BC Professional Firefighters Burn and Wound Healing Laboratory.